Boston Scientific sales hit $1.89B in Q3 & more – 4 GI company key notes

Here are four recent news updates on key gastroenterology and endoscopy companies.

Advertisement

Boston Scientific generated approximately $1.89 billion in sales for the third quarter of 2015, a 9 percent growth in operational revenue growth.

Shares of EndoChoice hit a 52-week low of $9.71 this week, according to a District of Columbia Progressive report. The company’s stock has a 50-day moving average of $12.78 and a 200-day moving average of $15.02.

Shares of Exact Sciences dropped 58.1 percent during the past four weeks, according to Insider Trading Report. The company’s shares have a one-year high of $32.85 and a one-year low of $6.79.

The endoscopy division of FUJIFILM Medical Systems will feature its ultrasound processor Sonart and EB-530US ultrasound bronchoscope at the annual meeting of the American College of Chest Physicians Oct. 24 to Oct. 28 in Montreal, Canada.

If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.

More articles on gastroenterology:
4 GI physicians in the news – Oct. 23, 2015
Lovelace Medical Group adds Dr. Julie Farrer: 3 things to know
3 top risk factors for failed fecal transplants

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.